Improves access to lower-cost generic and biosimilar drugs.
Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars
Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars
Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (RE1 NO IMPACT See Note)
Expedited Access to Biosimilars Act
To Mandate The Use Of Biosimilar Medicines Under Health Benefit Plans; To Require A Healthcare Provider To Prescribe Biosimilar Medicines; And To Improve Access To Biosimilar Medicines.
Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars.
Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.